A preterm female infant born of 32 weeks gestational age was presenting with musculoskeletal abnormalities, and cholestasis that later on resolved. Later on, she developed renal tubular acidosis (RTA), poor weight gain, unexplained intermittent fever and recurrent spontaneous bleeding episodes. ARC is an acronym that stands for arthrogryposis, renal dysfunction and cholestasis. ARC syndrome is a rare disorder that is difficult to diagnose and is associated with poor outcomes. We present a case of ARC syndrome in an infant with a history of failure to thrive, early cholestasis and RTA. There are many unique features about this case that should add to our understanding of this genetic condition. To our knowledge this is the first identified case of ARC syndrome in a preterm infant. Although the specific mutation found in our patient has not been reported previously, the type and location of this mutation is consistent with our genetic understanding of this disorder.
CASE
A 32-week preterm female infant was born via spontaneous vaginal delivery. The mother was a 27-year-old Caucasian multigravida with three fetal losses but four other living children. The biological father was the same for all pregnancies. The infant was symmetrically small for gestational age, with birth weight, length and head circumference all below 5th percentile. The infant's initial exam was notable for mild respiratory distress that required nasal continuous positive airway pressure and she was rapidly weaned off it. The abdomen was soft without organomegaly. Musculoskeletal abnormalities included slightly clenched fingers, mild abduction contractures of shoulders, limited flexion of hip joints and rocker-bottom feet. She developed mild jaundice consistent with physiological hyperbilirubinemia during the first week of age. However, during the third week of age she was jaundiced again with acholic stools. The direct bilirubin fraction was markedly elevated at 7.7 mg dl À 1 with total bilirubin level at 11.6 mg dl À 1 . Serum alkaline phosphatase was also markedly elevated (1349 U l À 1 ) but several other liver function tests, including total protein and albumin, were within normal limits for age. Abdominal ultrasonography showed normal liver echogenicity and the biliary tract was well visualized. A bone marrow aspirate was performed due to unusually moderate and persistent anemia (Hct 22-25%). It was essentially normal, showing mild erythroid hyperplasia. Additionally, serum total bile acids level was mildly elevated. A cytomegalovirus antigen test of urine was negative. At this point, the infant was started on ursodeoxycholic acid with subsequent normalization of bilirubin during the next 6 weeks. Since 2nd month of age the infant had intermittent unexplained fever (38.2 to 38.8 1C) with negative sepsis evaluation.
She had been receiving full parenteral nutrition due to poor weight gain with an estimated caloric intake of 150 kcal kg À 1 per day since the 1st week of age.
The patient always had stable blood glucose levels and did not appear acutely ill, but she had moderate metabolic acidosis. Renal tubular acidosis (RTA) was suspected and confirmed by the presence of proteinuria, glucosuria and phosphaturia, suggesting a Fanconi type of RTA.
Consequently, further work up of RTA included fractionated urine for reducing substances, and measurement of amino acids and organic acids in the urine, all of which were negative. Leukocyte cysteine evaluation and creatine/guanidinoacetate assay were also negative. Renal ultrasound showed bilateral moderate renal pelviectasis, but a subsequent voiding cystourethrogram was normal. A renal biopsy was considered, but was never done.
The infant continued to grow poorly despite aggressive fluid and nutritional support, to manage profound mineral and electrolyte losses. At 3 months of age her weight was well below the 3rd percentile.
In view of cholestasis, persistent and severe RTA, along with several mildly dysmorphic features, prompted the evaluation for ARC syndrome. Electron microscopic examination of platelets ultrastructure revealed abnormal or absent a-granules in virtually all platelet profiles. These findings are consistent with the diagnosis of ARC. Final confirmation was made by genetic analysis.
DISCUSSION
We present a preterm infant born at 32 weeks gestational age with musculoskeletal abnormalities, cholestasis, RTA, poor weight gain, unexplained intermittent fever and recurrent spontaneous bleeding episodes. ARC is an acronym that stands for arthrogryposis, renal tubular dysfunction and cholestasis. ARC syndrome is inherited as an autosomal recessive disorder. Abnormalities in the VPS33B gene have been shown to be associated with ARC syndrome. 1 The VPS33B gene is located on chromosome 15p26.1, and its gene product is a cytosolic protein involved in vesicle membrane fusion. Overall, 75% of ARC cases are due to abnormalities in VPS33B gene. 2 Arthrogryposis is joint contractures that develop prenatally and are evident at birth. Those newborns with arthrogryposis lack the normal range of motion in one or more joints due to decreased fetal movement. 3 Clubfoot and dislocation of the hip joint are frequently observed. The presence of 'rocker-bottom' feet was assessed as nonspecific dysmorphism by Bull et al., 4 but can be considered as part of the arthrogryposis spectrum. 5 As in our case, abduction contractures of shoulders, limited hip flexion and rocker-bottom feet were evident.
RTA (Fanconi type) is the most striking renal abnormality in ARC, but many patients can have features of nephrogenic diabetes insipidus and hypernatremic dehydration. 5 Renal ultrasound and biopsy can show poor cortico-medullary differentiation, nephrocalcinosis and tubular atrophy. RTA was noted in our case, and with a follow-up ultrasound at 2 months of age revealed nephrocalcinosis as well.
Cholestasis in patients with ARC can be extremely variable and the level of bilirubin in a patient can fluctuate between extremely high and normal levels. Cholestatic liver disease in ARC is associated with normal or only slightly (less than two fold) elevations in alanine aminotransferase and aspartate aminotransferase. Non-excreting biliary isotope studies might suggest biliary obstruction or severe intrahepatic cholestasis. Liver biopsy features can include bile duct paucity and lipofuscin deposition. Mild giant cell transformation of hepatocytes associated with neonatal hepatitis and portal fibrosis can be seen. 5 They can also develop acute hepatic failure. However, only early cholestasis was evident in our patient that resolved by 2 months of age. A liver biopsy was therefore not considered.
Once ARC syndrome is suspected clinically, a diagnosis can be made by performing liver and kidney biopsies; however, biopsies in these patients have been complicated by significant bleeding despite normal clotting studies and platelet count. A less invasive, but equally suggestive finding is the presence of a congenital platelet defect similar to the gray platelet syndrome. 6 In patients with ARC morphologic studies of platelets revealed abnormal platelets characterized by a severe reduction in a-granule number and contents as was evident in our case. 7 Most cases of ARC syndrome are associated with germline VPS33B mutations. Nonsense and splice site mutations represent the most common forms of VPS33B mutation, although missense and frame-shifting mutations have also been reported. Mutations in the VIPAR gene, which encodes a 'VPS33B-interacting protein', have been found in all cases of classic ARC syndrome when VPS33B mutations were not identified. 2 All reported VIPAR mutations result in premature protein termination. The VIPAR gene is located on chromosome 14q24 and consists of 19 coding exons. Also referred to as C14orf133, this gene encodes a protein that interacts with the VPS33B gene product to regulate membrane fusion. In our case, based on the clinical features and platelet abnormalities, we suspected ARC syndrome and confirmed the condition by mutation analysis, which showed that the patient is homozygous in exon 8 of the VIPAR gene for a mutation defined as c.484C4T that is predicted to result in premature protein termination (p.Arg162Stop).
To our knowledge, this is the first identified case of ARC syndrome in a preterm infant. Although the specific mutation found in our patient has not been reported previously, the type and location of this mutation is consistent with our genetic understanding of this disorder. Although ARC syndrome has been traditionally described by the three cardinal features of arthrogryposis, renal dysfunction and cholestasis, it has been noted that ARC syndrome has an expanding range of phenotypes;which was certainly true in our case. The most obvious clinical features in our patient were failure to thrive, and profound Fanconi-type RTA. Neither cholestasis nor arthrogryposis was prominent features. Early cholestasis was present but it resolved with conservative medical management. Although there were some musculoskeletal abnormalities with limited range of motion, frank arthrogryposis was not present. The fact that arthtogryposis may not be a prominent feature in many cases of ARC has been previously reported. 8 Given the wide-ranging phenotypes that may be included in ARC syndrome, it is possible that this disorder is not as rare as previously thought, but perhaps underdiagnosed. 9 We suggest, therefore, that ARC syndrome should be included in the differential diagnosis of early, atypical neonatal cholestasis and/or renal dysfunction of the RTA type, especially when either is associated with poor growth or joint abnormalities. Once ARC syndrome is suspected, a morphologic study of platelets would help in diagnosis, and then genetic testing can confirm it. 10 
